1. Epidermal growth factor;Carpenter;J Biol Chem,1990
2. EGFR antagonists in cancer treatment;Ciardiello;N Engl J Med,2008
3. Phase I PK/PD study of RO5083945 (GA201), the first glycoengineered anti-EGFR monoclonal antibody (mAb) with optimized antibody dependent cellular cytotoxicity (ADCC);Markman;J Clin Oncol,2010
4. A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies;Kuenen;Clin Cancer Res,2010
5. A dose-escalation phase I trial of nimotuzumab an antibody against the epidermal growth factor receptor in patients with advanced solid malignancies;You;Invest New Drugs,2010